ArticleScientific reports2025
Carotid intima media thickness, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio in multiple sclerosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis.Molecular neurobiology · 2026Review
- Body mass index mediates the association between neutrophil-to-lymphocyte ratio and impaired fasting glucose: evidence from a five-year follow-up study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence on carotid intima-media thickness (cIMT), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in patients with multiple sclerosis (MS) is limited. We aimed to assess cIMT, NLR, and PLR levels, and their potential associations in patients with MS. This case-control study included 110 patients with MS and 110 healthy controls. All participants underwent comprehensive history taking, as well as general and neurological examinations. Disability was assessed using the Expanded Disability Status Scale (EDSS). cIMT was measured by B-mode ultrasound, 10 mm before the bifurcation of the common carotid artery. Compared to healthy controls, patients with MS demonstrated significantly elevated NLR, PLR, and cIMT values, even after adjustment for age, gender, and BMI (P < 0.001). Within the MS group, higher cIMT values were significantly associated with secondary progressive MS type (P = 0.003) and correlated with higher EDSS scores (P < 0.001); however, these findings lost statistical significance after controlling for age, gender, and BMI. NLR and PLR demonstrated acceptable diagnostic accuracy for MS, while mean cIMT showed excellent discriminative ability. All three markers-NLR, PLR, and mean cIMT-exhibited acceptable performance in assessing disease severity. MS is associated with significantly elevated levels of NLR, PLR, and cIMT. While cIMT was not associated with NLR or PLR, it may serve as a valuable, non-invasive tool for evaluating vascular involvement and disease progression in MS. Further multi-center studies with larger cohorts are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.